BioLife Solutions Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	29.48	95.39	27.9	19.44	69.86	90.4
Short-Term Investments	49.47	9.2	16.29	43.26	-	-
Cash & Short-Term Investments	78.95	104.58	44.18	62.7	69.86	90.4
Cash Growth	130.94%	136.70%	-29.53%	-10.25%	-22.72%	1302.03%
Receivables	10.84	9.17	7.9	33.94	23.22	8.01
Inventory	27.83	29.01	27.16	34.9	28.35	11.6
Prepaid Expenses	8.95	6	4.67	6.88	4.66	4.65
Restricted Cash	-	-	-	0.03	0.01	0.05
Other Current Assets	-	-	36.69	-	-	-
Total Current Assets	126.57	148.76	120.6	138.45	126.09	114.71
Property, Plant & Equipment	23.9	22.86	19.48	48.27	46.61	24.52
Long-Term Investments	19.44	5.62	5.62	6.4	4.37	5.87
Goodwill	212.3	212.3	212.3	224.74	224.74	58.45
Other Intangible Assets	7.45	9.56	12	32.09	152.15	31.05
Other Long-Term Assets	2.42	0.38	42.71	0.28	0.33	0.23
Total Assets	392.08	399.49	412.71	450.23	554.29	234.83
Accounts Payable	2.89	3.57	2.27	15.37	14.95	3.67
Accrued Expenses	14.43	16.6	13.22	12.36	8.6	3.37
Current Portion of Long-Term Debt	7.49	10.94	6.29	1.81	0.86	0.61
Current Portion of Leases	2.18	1.51	1.29	3.02	2.91	1.12
Current Income Taxes Payable	-	-	0.26	0.98	0.03	0.11
Current Unearned Revenue	0.15	0.1	0.04	0.55	0.81	0.93
Other Current Liabilities	-	-	18.82	10.5	14.55	5.76
Total Current Liabilities	27.15	32.73	42.18	44.58	42.7	15.57
Long-Term Debt	-	5	17.56	23.79	6.35	0.66
Long-Term Leases	11.01	12.72	8.7	15.09	16.76	8.77
Long-Term Deferred Tax Liabilities	0.19	0.12	0.11	0.25	5.49	-
Other Long-Term Liabilities	-	-	6.5	2.33	4.94	4.59
Total Liabilities	38.34	50.58	75.05	86.04	76.24	29.58
Common Stock	0.05	0.05	0.05	0.04	0.04	0.03
Additional Paid-In Capital	704.33	683.94	652.88	611.74	585.4	302.6
Retained Earnings	-350.77	-335.1	-314.92	-246.92	-107.11	-97.39
Comprehensive Income & Other	0.13	0.02	-0.35	-0.68	-0.28	-
Total Common Equity	353.74	348.91	337.66	364.19	478.05	205.25
Shareholders' Equity	353.74	348.91	337.66	364.19	478.05	205.25
Total Liabilities & Equity	392.08	399.49	412.71	450.23	554.29	234.83
Total Debt	20.68	30.17	33.83	43.71	26.88	11.15
Net Cash (Debt)	77.72	79.04	10.91	18.99	42.98	79.25
Net Cash Growth	-	624.79%	-42.57%	-55.82%	-45.77%	1459.73%
Net Cash Per Share	1.64	1.72	0.25	0.44	1.12	2.90
Filing Date Shares Outstanding	48.15	47	45.3	43.21	42.09	33.4
Total Common Shares Outstanding	47.97	46.91	45.17	42.83	41.82	33.04
Working Capital	99.42	116.03	78.43	93.87	83.39	99.14
Book Value Per Share	7.37	7.44	7.48	8.50	11.43	6.21
Tangible Book Value	133.99	127.05	113.36	107.36	101.16	115.75
Tangible Book Value Per Share	2.79	2.71	2.51	2.51	2.42	3.50
Machinery	14.51	13.88	13.8	30.14	24.18	14.15
Construction In Progress	9.53	5.58	5.16	6.75	4.42	2.54
Leasehold Improvements	3.59	3.53	3.5	5.25	3.84	2.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.